TY  - JOUR
AU  - Crespo-Facorro, Benedicto
AU  - Ruiz-Veguilla, Miguel
AU  - Vazquez-Bourgon, Javier
AU  - Sanchez-Hidalgo, Ana C
AU  - Garrido-Torres, Nathalia
AU  - Cisneros, Jose M
AU  - Prieto, Carlos
AU  - Sainz, Jesus
PY  - 2021
DO  - 10.3389/fphar.2021.646701
SN  - 1663-9812
UR  - https://hdl.handle.net/10668/27392
T2  - Frontiers in pharmacology
AB  - Antipsychotics modulate expression of inflammatory cytokines and inducible inflammatory enzymes. Elopiprazole (a phenylpiperazine antipsychotic drug in phase 1) has been characterized as a therapeutic drug to treat SARS-CoV-2 infection in a...
LA  - en
PB  - Frontiers Research Foundation
KW  - SARS-CoV-2
KW  - coronavirus
KW  - elopiprazole
KW  - immunology
KW  - inflammation
KW  - psychosis
KW  - repurposing drugs
KW  - Humans
KW  - Antipsychotic Agents
KW  - phenylpiperazine
KW  - Transcriptome
KW  - Drug Repositioning
KW  - Gene Expression Profiling
KW  - Immunity
KW  - Psychotic Disorders
KW  - Signal Transduction
KW  - Receptors, Antigen, B-Cell
TI  - Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.
TY  - research article
VL  - 12
ER  -